15,652 Shares in Phibro Animal Health Co. (NASDAQ:PAHC) Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP purchased a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 15,652 shares of the company’s stock, valued at approximately $272,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Copper Rock Capital Partners LLC increased its holdings in Phibro Animal Health by 12,929.9% in the 2nd quarter. Copper Rock Capital Partners LLC now owns 23,830,267 shares of the company’s stock valued at $593,033,000 after buying an additional 23,647,378 shares during the period. State Street Corp increased its holdings in Phibro Animal Health by 5.4% in the 1st quarter. State Street Corp now owns 727,749 shares of the company’s stock valued at $17,590,000 after buying an additional 37,495 shares during the period. FMR LLC increased its holdings in Phibro Animal Health by 82.7% in the 1st quarter. FMR LLC now owns 337,652 shares of the company’s stock valued at $11,143,000 after buying an additional 152,853 shares during the period. Chartwell Investment Partners LLC increased its holdings in Phibro Animal Health by 4.7% in the 2nd quarter. Chartwell Investment Partners LLC now owns 317,371 shares of the company’s stock valued at $8,337,000 after buying an additional 14,305 shares during the period. Finally, Raymond James & Associates increased its holdings in Phibro Animal Health by 15.8% in the 2nd quarter. Raymond James & Associates now owns 193,081 shares of the company’s stock valued at $5,072,000 after buying an additional 26,354 shares during the period.

Shares of Phibro Animal Health stock opened at $19.21 on Friday. The firm’s 50 day moving average is $17.95 and its 200 day moving average is $21.59. The company has a current ratio of 2.87, a quick ratio of 1.62 and a debt-to-equity ratio of 1.96. Phibro Animal Health Co. has a 1 year low of $16.27 and a 1 year high of $29.38. The firm has a market capitalization of $777.10 million, a PE ratio of 23.43, a price-to-earnings-growth ratio of 1.56 and a beta of 0.37.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Monday, November 9th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.21 by $0.06. Phibro Animal Health had a net margin of 4.19% and a return on equity of 21.69%. As a group, research analysts anticipate that Phibro Animal Health Co. will post 1.15 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 16th. Investors of record on Wednesday, November 25th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, November 24th. This represents a $0.48 annualized dividend and a yield of 2.50%. Phibro Animal Health’s dividend payout ratio is presently 44.44%.

Several equities analysts have commented on the stock. Morgan Stanley lowered shares of Phibro Animal Health from an “equal weight” rating to an “underweight” rating and set a $20.00 target price on the stock. in a report on Thursday, August 6th. ValuEngine lowered shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Thursday, October 1st. BidaskClub lowered shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Friday, September 4th. Finally, Zacks Investment Research lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating and set a $18.00 price target on the stock. in a report on Tuesday, November 3rd. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $22.80.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

See Also: Marijuana Stocks

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.